Abstract
Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. In this article, we review the burden of migraine, emphasizing the population-based studies that used standardized diagnostic criteria. We highlight descriptive epidemiology, burden of disease, patterns of diagnosis, and treatment. We focus on the epidemiology and burden of probable migraine, a subtype of migraine where just one clinical feature is missing. We finish by describing approaches to improving healthcare delivery for migraine and probable migraine. Although migraine is a remarkably common cause of temporary disability, many migraineurs, even those with disabling headache, have never consulted a physician for the problem. Prevalence is highest in women, in persons between the ages of 25 and 55 years, and, at least in the United States, in individuals from low-income households. Nonetheless, prevalence is high in groups other than these high-risk groups. Probable migraine is a prevalent form of migraine, and like migraine with and without aura it produces decrements in health-related quality of life and increments in disability relative to control subjects.
Similar content being viewed by others
References and Recommended Reading
Linet MS, Celentano DD, Stewart WF: Headache characteristics associated with physician consultation: a population-based survey. Am J Prev Med 1991, 7:40–46.
Pascual J, Combarros O, Leno C, et al.: Distribution of headache by diagnosis as the reason for neurologic consultation. Med Clin 1995, 104:161–164.
Scher AI, Stewart WF, Lipton RB: Migraine and headache: a meta-analytic approach. In Epidemiology of Pain. Edited by Crombie IK. Seattle, WA: IASP Press; 1999:159–170.
Rasmussen BK: Epidemiology of headache. Cephalalgia 1995, 15:45–68.
Lipton RB, Amatniek JC, Ferrari MD, et al.: Migraine: identifying and removing barriers to care. Neurology 1994, 44(supp l6):56–62.
Headache classification committee of the International Headache Society: The International Classification of Headache Disorders. Cephalalgia 2004, 24(suppl 1);1–160.
Lipton RB, Stewart WF, Simon D: Medical consultation for migraine: results from the American Migraine Study. Headache 1998, 38:91–96.
Lipton RB, Diamond S, Reed M, et al.: Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001, 41:638–645. Important study.
Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646–657. Important study.
Waters WE: Headache (Series in Clinical Epidemiology). Littleton, MA: PSG Co; 1986.
Headache classification committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1–96.
Stewart WF, Linet MS, Celentano DD, et al.: Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1993, 34:1111–1120.
Breslau N, Davis GC, Schultz LR, Peterson EL: Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 1994, 34:387–393.
Stang PE, Yanagihara T, Swanson JW, et al.: Incidence of migraine headaches: a population-based study in Olmsted County, Minnesota. Neurology 1992, 42:1657–1662.
Lipton RB, Stewart WF, Celentano DD, Reed ML: Undiagnosed migraine: a comparison of symptom-based and self-reported physician diagnosis. Arch Intern Med 1992, 152:1273–1278.
Lyngberg A, Jensen R, Rasmussen BK, Jorgensen T: Incidence of migraine in a Danish population-based follow-up study [abstract]. Cephalalgia 2003, 23:596.
Stewart WF, Simon D, Shechter A, Lipton RB: Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol 1995, 48:269–280.
Henry P, Michel P, Brochet B, et al.: A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 1992, 12:229–237.
Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM Study. Neurology 1999, 53:537–542.
Steiner T, Scher A, Stewart W, et al.: The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003, 23:519–527.
Sillanpaa M: Prevalence of migraine and other headache in Finnish children starting school. Headache 1976, 15:288–290.
Amayo EO, Jowi JO, Njeru EK: Headache associated disability in medical students at the Kenyatta National Hospital, Nairobi. East Afr Med J 2002, 79:519–523.
Orji GI, Iloeje SO: Childhood migraine in Nigeria—I: a community-based study. West Afr J Med 1997, 16:208–217.
Matuja WB, Mteza IB, Rwiza HT: Headache in a nonclinical population in Dar es Salaam, Tanzania. A community-based study. Headache 1995, 35:273–276.
Bille B: Migraine in school children. Acta Paediatr Scand 1962, 51(suppl 136):1–151.
Bille B: Migraine in children: prevalence, clinical features, and a 30-year follow-up. In Migraine and Other Headaches. Edited by Ferrari MD, Lataste X. New Jersey: Parthenon; 1989.
Sillanpaa M: Prevalence of migraine and other headache in Finnish children starting school. Headache 1976, 15:288–290.
Sillanpaa M: Prevalence of headache in prepuberty. Headache 1983, 23:10–14.
Silberstein SD, Merriam GR: Sex hormones and headache. In Blue Books of Practical Neurology: Headache. Edited by Goadsby P, Silberstein SD. Boston: Butterworth Heinemann; 1997:143–176.
Waters WE: Migraine: intelligence, social class, and familial prevalence. BMJ 1971, 2:77–81.
Stang PE, Sternfeld B, Sidney S: Migraine headache in a prepaid health plan: ascertainment, demographics, physiological and behavioral factors. Headache 1996, 36:69–76.
Stang PE, Osterhaus JT: Impact of migraine in the United States: data from the National Health Interview Survey. Headache 1993, 33:29–35.
Feinstein AR: The pretherapeutic classification of comorbidity in chronic disease. J Chronic Dis 1970, 23:455–468.
Lipton RB, Silberstein SD: Why study the comorbidity of migraine. Neurology 1994, 44:4–5.
Hu XH, Markson LE, Lipton RB, et al.: Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999, 159:813–818.
Lipton RB, Bigal ME, Kolodner K, et al.: The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003, 23:429–440.
Osterhaus JT, Gutterman DL, Plachetka JR: Health care resources and lost labor costs of migraine headaches in the United States. Pharmacoeconomics 1992, 2:67–76.
Holmes WF, MacGregor A, Dodick D: Migraine-related disability: impact and implications for sufferers’ lives and clinical issues. Neurology 2001, 56(suppl 1):S13-S19.
Celentano DD, Stewart WF, Lipton RB, Reed ML: Medication use and disability among migraineurs: a national probability sample. Headache 1992, 32:223–228.
Fry J: Profiles of Disease. Edinburgh: Livingstone; 1996.
Consumer Healthcare Products Association: OTC Sales Statistics: 1995–1999. New York: AC Neilsen; April, 2000.
Rains JC, Penzien DB, Lipchik GL, et al.: Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia 2001, 21:584–595.
Russell MB, Olesen J: Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study. Cephalalgia 1996, 16:431–435.
Lipton RB, Stewart WF, von Korff M: Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997, 48(suppl 3):4–9.
Cady RC, Ryan R, Jhingran P, et al.: Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998, 158:1013–1018.
Dahlof C, Bouchard J, Cortelli P, et al.: A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. Pharmacoeconomics 1997, 11(suppl 1):24–34.
Santanello NC, Polis AB, Hartmaier SL, et al.: Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia 1997, 17:867–872.
Lipton RB, Dodick D, Sadovsky R, et al.: A self-administered screener for migraine in primary care: the ID Migraine(TM) validation study. Neurology 2003, 61:375–382.
Matchar DB, Young WB, Rosenerg J, et al.: Multispecialty consensus on diagnosis and treatment of headache: pharmacological management of acute attacks. Neurology 2000, 54. http://www.aan.com/public/practiceguidelines/03.pdf.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bigal, M.E., Lipton, R.B. & Stewart, W.F. The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 4, 98–104 (2004). https://doi.org/10.1007/s11910-004-0022-8
Issue Date:
DOI: https://doi.org/10.1007/s11910-004-0022-8